Amoy Diagnostics Co (SZSE:300685) Marketable Securities : ¥382 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Amoy Diagnostics Co Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Amoy Diagnostics Co's Marketable Securities for the quarter that ended in Mar. 2024 was ¥382 Mil.

Amoy Diagnostics Co's annual Marketable Securities declined from Dec. 2021 (¥316 Mil) to Dec. 2022 (¥259 Mil) but then increased from Dec. 2022 (¥259 Mil) to Dec. 2023 (¥469 Mil).

Amoy Diagnostics Co Marketable Securities Historical Data

The historical data trend for Amoy Diagnostics Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amoy Diagnostics Co Marketable Securities Chart

Amoy Diagnostics Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

30.06

304.86

315.85

259.30

469.12

Amoy Diagnostics Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															275.57	274.73	349.94	469.12	382.41

Amoy Diagnostics Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Amoy Diagnostics Co (SZSE:300685) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Amoy Diagnostics Co Marketable Securities Related Terms

Thank you for viewing the detailed overview of Amoy Diagnostics Co's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Amoy Diagnostics Co (SZSE:300685) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Amoy Diagnostics Co Ltd (SZSE:300685) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

39 Dingshan Road, Haicang District, Xiamen, CHN, 361027

Website

http://www.amoydx.com

Amoy Diagnostics Co Ltd is the pharmaceutical company based in China. The company primarily focuses on molecular diagnostics for oncology precision medicine. It provides diagnostic products and services for medicine development and clinical oncology practice. The company's products include gene mutation, nucleic acid extraction, and molecular diagnostic kits comprising EGFR, RAS, ALK, BRAF, PIK3CA, and ROS1 testing kits.

Executives

Ruan Li	Directors, executives
Zheng Hui Bin	Directors, executives
Chen Ying	Directors, executives
Luo Jie Min	Executives
Zhu Guan Shan	Directors, executives
Yang Shou Qian	Securities Affairs Representative
Zhou Wen Gang	Executives
Zhou Xue Lin	Independent director
Hu Xu Bo	Director

Amoy Diagnostics Co (SZSE:300685) Headlines

No Headlines